Results 171 to 180 of about 6,789 (241)

Tailoring obeticholic acid activity by iridium(III) complex conjugation to develop a farnesoid X receptor probe. [PDF]

J Adv Res
Niu D, Wu X, Zhang Y, Wang X, Shiu-Hin Chan D, Jing S, Wong CY, Wang W, Leung CH.   +8 more
europepmc   +1 more source

Non-alcoholic fatty liver disease [PDF]

, 2017
Brent A. Neuschwander-Tetri
core   +1 more source

Hepatic real-world outcomes with obeticholic acid in primary biliary cholangitis (HEROES): A trial emulation study design. [PDF]

Hepatology
Brookhart MA, Mayne TJ, Coombs C, Breskin A, Ness E, Bessonova L, Chu YJ, Li J, Fried MW, Hansen BE, Kowdley KV, Jones D, Mells G, Trivedi PJ, Hiu S, Kareithi DN, Wason J, Smith R, Seeger JD, Hirschfield GM.   +19 more
europepmc   +1 more source

How to Face Chronic Liver Disease: The Sinusoidal Perspective [PDF]

, 2017
Anabel Fernández-Iglesias, Jordi Gracia-Sancho   +1 more
core   +1 more source

Obeticholic Acid Improves Cholestasis, Liver Fibrosis, and Liver Function in Patients with Primary Biliary Cholangitis with Inadequate Response to Ursodeoxycholic Acid. [PDF]

J Pers Med
Buechter M, Manka P, Bulut K, Gerken G, Kahraman A.   +4 more
europepmc   +1 more source

COBALT: A Confirmatory Trial of Obeticholic Acid in Primary Biliary Cholangitis With Placebo and External Controls. [PDF]

Am J Gastroenterol
Kowdley KV, Hirschfield GM, Coombs C, Malecha ES, Bessonova L, Li J, Rathnayaka N, Mells G, Jones DE, Trivedi PJ, Hansen BE, Smith R, Wason J, Wason J, Hiu S, Kareithi DN, Mason AL, Bowlus CL, Muller K, Carbone M, Berenguer M, Milkiewicz P, Adekunle F, Villamil A.   +23 more
europepmc   +1 more source

Role of Obeticholic Acid, a Farnesoid X Receptor Agonist, in Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis. [PDF]

touchREV Endocrinol
Kamrul-Hasan A, Mondal S, Nagendra L, Sasikanth T, Ahammed A, Rahman S, Wickramarachchi A, Parajuli N, Khatiwada S, Dutta D.   +9 more
europepmc   +1 more source

ROS-responsive nanoparticle delivery of obeticholic acid mitigate primary sclerosing cholangitis

Qigu Yao, Beiduo Wang, Jiong Yu, Qiaoling Pan, Yingduo Yu, Xudong Feng, Wenyi Chen, Jinfeng Yang, Changyou Gao, Hongcui Cao   +9 more
openalex   +1 more source

Obeticholic acid ameliorates sepsis-induced renal mitochondrial damage by inhibiting the NF-κb signaling pathway. [PDF]

Ren Fail
Jing D, Liu J, Qin D, Lin J, Li T, Li Y, Duan M.   +6 more
europepmc   +1 more source

The effect and safety of obeticholic acid for patients with nonalcoholic steatohepatitis: A systematic review and meta-analysis of randomized controlled trials. [PDF]

Medicine (Baltimore)
Zhao J, Li B, Zhang K, Zhu Z.
europepmc   +1 more source